Medpace Holdings Inc (MEDP)

Return on assets (ROA)

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net income (ttm)	US$ in thousands	282,810	273,182	268,659	256,951	245,368	226,732	209,279	199,853	181,848	182,680	175,566	159,736	145,384	124,331	106,848	110,199	100,443	93,391	88,719	77,832
Total assets	US$ in thousands	1,656,830	1,486,720	1,406,940	1,395,720	1,352,500	1,328,420	1,315,450	1,344,350	1,659,940	1,577,140	1,469,710	1,451,360	1,390,680	1,296,140	1,222,130	1,137,630	1,143,070	1,072,330	1,016,860	1,006,520
ROA		17.07%	18.37%	19.10%	18.41%	18.14%	17.07%	15.91%	14.87%	10.96%	11.58%	11.95%	11.01%	10.45%	9.59%	8.74%	9.69%	8.79%	8.71%	8.72%	7.73%

December 31, 2023 calculation

ROA = Net income (ttm) ÷ Total assets
= $282,810K ÷ $1,656,830K
= 17.07%

Medpace Holdings Inc's return on assets (ROA) has shown a consistent upward trend over the past eight quarters, increasing from 14.84% in Q1 2022 to 19.08% in Q2 2023. This indicates that the company has been effectively utilizing its assets to generate profit. The ROA percentages are generally above 15%, which indicates that Medpace Holdings Inc is efficient in generating profits relative to its total assets. However, it is worth noting that there was a slight decrease in Q3 2023 compared to the previous quarter, which could be an area of concern that requires further investigation. Overall, the trend suggests that Medpace Holdings Inc is effectively managing its assets to generate profits, but monitoring future performance is essential to ensure sustained efficiency.